Isoniazid/pyrazinamide/rifampicinHepatitis: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1818卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82438-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：158 / 158

相关论文

共 50 条

[21] Rifampicin/isoniazid/pyrazinamide/ethambutolAdverse cutaneous drug reactions to excipients: 4 case reports
Reactions Weekly, 2022, 1926 (1) : 412 - 412
[22] Ethambutol/isoniazid/pyrazinamide/rifampicinDrug-related liver injury: 57 case reports
Reactions Weekly, 2015, 1557 (1) : 98 - 98
[23] Isoniazid/rifampicinVarious toxicities: 5 case reports
Reactions Weekly, 2022, 1896 (1) : 258 - 258
[24] Rifampicin/isoniazid/pyrazinamide/ethambutol and Isoniazid/rifampicinDrug resistance in rifampicin-susceptible pulmonary tuberculosis : 2 case reports
Reactions Weekly, 2017, 1678 (1) : 155 - 155
[25] Isoniazid/pyrazinamide/rifampicinLiver failure: case report
Reactions Weekly, 2010, 1290 (1) : 30 - 30
[26] Ethambutol/isoniazid/pyrazinamide/rifampicinCutaneous leucocytoclastic vasculitis with gastrointestinal tract involvement: 2 case reports
Reactions Weekly, 2016, 1583 (1) : 471 - 471
[27] Isoniazid/pyrazinamide/rifampicinSplenic abscess: case report
Reactions Weekly, 2010, 1302 (1) : 31 - 31
[28] Isoniazid/pyrazinamide/rifampicinVarious toxicities: case report
Reactions Weekly, 2015, 1545 (1) : 144 - 144
[29] Isoniazid/pyrazinamide/rifampicinTreatment failure: case report
Reactions Weekly, 2023, 1954 (1) : 264 - 264
[30] Isoniazid/pyrazinamide/rifampicin interactionHepatitis: case report
Reactions Weekly, 2010, 1292 (1) : 22 - 22

← 1 2 3 4 5 →